Personalized Treatment for Patients With Premature Ventricular Beats
Launched by OSLO UNIVERSITY HOSPITAL · Oct 30, 2020
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a special imaging test called cardiac MRI can help doctors understand and treat a common heart issue known as premature ventricular beats (PVBs). PVBs are extra heartbeats that can make some people feel anxious or uncomfortable, and sometimes they can affect how well the heart works. The trial aims to find out if cardiac MRI is the best way to check for any underlying heart problems and whether certain heart rate measurements can help guide treatment during procedures to address PVBs.
To participate in the trial, you need to be someone who has been referred for a specific treatment called PVC ablation, which targets these extra heartbeats. The trial is open to adults aged 18 and older, and both men and women can join. If you take part, you'll undergo tests to see how effective cardiac MRI is in diagnosing potential heart issues related to PVBs, and your experience may help shape future treatments for others with similar heart conditions.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Patients referred for PVC ablation
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Oslo, , Norway
Patients applied
Trial Officials
Mathis K Stokke, MD PhD
Principal Investigator
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials